{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "52028284",
    "validDate": "2027-03-22 00:00:00.000",
    "issueDate": "2022-03-22 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202828400",
    "prodNameC": "萊利邁膠囊15毫克",
    "prodNameE": "LELIMIDE 15 (Lenalidomide Capsules 15mg)",
    "indicationsName": [
        "1. 多發性骨髓瘤(Multiple Myeloma，MM)： \r\n(1) 與dexamethasone、與bortezomib及dexamethasone、或與melphalan及prednisone合併使用治療不適合接受移植之新診斷多發性骨髓瘤(multiple myeloma，MM)成年病人。\r\n(2) 單一療法適用於做為已接受自體造血幹細胞移植之新診斷多發性骨髓瘤成年病人的維持治療用藥。\r\n(3) 與dexamethasone合併使用可治療先前已接受至少一種治療失敗之多發性骨髓瘤病人。 \r\n2. 骨髓增生不良症候群(Myelodysplastic syndromes，MDS)：在其他治療方式不佳的情況下，Lenalidomide可單獨用於治療IPSS分級為低或中度(Intermediate-1)風險且單獨伴隨染色體5q缺失之骨髓增生不良症候群(Myelodysplastic syndromes，MDS)所導致的輸血依賴型貧血之成人病人。 \r\n3. 濾泡性淋巴瘤(Follicular Lymphoma，FL)：與rituximab合併使用，治療先前已接受過治療之濾泡性淋巴瘤(follicular lymphoma，FL)成年病人。"
    ],
    "does": "1130",
    "packageUnit": [
        {
            "packageSpec": "2-1000錠",
            "packageUnit": "KE"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": "B",
    "ingredientsDesc": [
        "LENALIDOMIDE"
    ],
    "restraintItemsCode": [
        "02",
        "1D",
        "24"
    ],
    "applicantName": "凱沛爾藥品有限公司",
    "applicantAddr": "臺北市信義區光復南路495號6樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "HETERO LABS LIMITED, UNIT V",
            "factoryAddr": "SY. NO 439, 440, 441 & 458, TSIIC FORMULATION SEZ, POLEPALLY VILLAGE, JADCHERLA MANDAL, MAHABOOBNAGAR DISTRICT, TELANGANA, INDIA ",
            "factoryCompanyAddr": "",
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN0780000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1008200300",
            "ingredientsDesc": "LENALIDOMIDE",
            "concentDesc": "Lenalidomide IH (Form H1)",
            "concent": "15.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "A6A760F1-9510-48DA-860D-395EE0AAA792",
            "approvedDocNo": "1129054085",
            "approvedDate": "2024-03-26",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "415E397E-952B-4977-AFD4-6585535DB377",
            "approvedDocNo": "1129054085",
            "approvedDate": "2024-03-26",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "7067D646-C230-4F53-9295-C8F75FFB7B9B",
            "approvedDocNo": "1129054085",
            "approvedDate": "2024-03-26",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AX04"
        }
    ],
    "licBaseId": "0AD18BFC-E84F-4DE1-8C95-A7A083062D8A"
}